Dr. Reddy's Laboratories
RDY
#1703
Rank
C$16.50 B
Marketcap
C$19.73
Share price
0.07%
Change (1 day)
-0.65%
Change (1 year)

Revenue for Dr. Reddy's Laboratories (RDY)

Revenue in 2025 (TTM): C$5.56 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current revenue (TTM ) is C$5.52 Billion. In 2024 the company made a revenue of C$5.31 Billion an increase over the revenue in the year 2023 that were of C$4.35 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Dr. Reddy's Laboratories from 2002 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) C$5.56 B4.83%
2024 C$5.31 B22.01%
2023 C$4.35 B8.01%
2022 C$4.02 B12.99%
2021 C$3.56 B11.43%
2020 C$3.20 B0.93%
2019 C$3.17 B7.71%
2018 C$2.94 B6.42%
2017 C$2.76 B-3.27%
2016 C$2.85 B-14.74%
2015 C$3.35 B22.81%
2014 C$2.73 B16.53%
2013 C$2.34 B23.07%
2012 C$1.90 B-0.57%
2011 C$1.91 B21.71%
2010 C$1.57 B-2.27%
2009 C$1.61 B-6.07%
2008 C$1.71 B34.44%
2007 C$1.27 B-12.06%
2006 C$1.45 B140.6%
2005 C$0.60 B13.94%
2004 C$0.52 B-3.73%
2003 C$0.54 B-5.02%
2002 C$0.57 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
C$87.60 B 1,486.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$23.40 B 323.89%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
C$59.09 B 970.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
C$78.65 B 1,324.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$66.30 B 1,100.85%๐Ÿ‡ซ๐Ÿ‡ท France